Stockscreener 앱 받기
1.72
3.91%
-0.07
시간 외 거래:
1.72
Organogenesis Holdings Inc 주식(ORGO)의 최신 뉴스
Organogenesis (ORGO) Q2 2026 Earnings Call Transcript - AOL.com
Organogenesis, lured to RI with tax credits, is bleeding money - The Business Journals
OrganiGram: Fiscal Q3 Earnings Snapshot - AOL.com
Organogenesis Holdings, Inc. Class A Revenue Breakdown – MUN:2PQ - TradingView
Organogenesis Holdings (ORGO) Stock Fair Value Moves Lower After Guidance Cut And Analyst Caution - Yahoo Finance
Organogenesis Holdings Inc (ORGO) Stock News Today - TradingKey
Organogenesis Holdings (ORGO) Is Down 21.5% After Slashing 2026 Guidance And Launching Equity Offering – Has The Bull Case Changed? - Yahoo Finance
Organogenesis (NASDAQ:ORGO) Cut to Strong Sell at Wall Street Zen - MarketBeat
Organogenesis Holdings Inc (ORGO) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Organogenesis Shares Plunge After Revenue Slump, Wider Loss and Lower Outlook - Moomoo
Truist Adjusts Price Target on Organogenesis to $2 From $3, Maintains Hold Rating - marketscreener.com
Truist Financial Has Lowered Expectations for Organogenesis (NASDAQ:ORGO) Stock Price - MarketBeat
Organogenesis Holdings Inc. Q2 2026 Earnings Call Summary - Yahoo Finance
Earnings call transcript: Organogenesis Q2 2026 miss sends shares lower By Investing.com - Investing.com Australia
Form 8K Organogenesis Holdings Inc For: 6 August By Investing.com - Investing.com Nigeria
Organogenesis Holdings Inc. (ORGO) Stock Analysis: Potential 24% Upside For Investors - DirectorsTalk Interviews
Organogenesis Q2 Earnings Call Highlights - Yahoo Finance
Organogenesis earnings missed by $0.42, revenue fell short of estimates - Investing.com Canada
Earnings call transcript: Organogenesis Q2 2026 miss sends shares lower - Investing.com
Organogenesis Holdings enters at-the-market sales agreement for up to $75 million - Investing.com
Transcript : Organogenesis Holdings Inc., Q2 2026 Earnings Call, Aug 06, 2026 - marketscreener.com
Organogenesis: Q2 Earnings Snapshot - Barchart.com
Organogenesis Holdings Inc. reports results for the quarter ended June 30Earnings Summary - tradingview.com
Organogenesis (Nasdaq: ORGO) sets up $75M at-the-market stock sale - Stock Titan
Organogenesis Holdings Inc. Q2 2026: Revenue $42.8M, EPS $(0.77) — 10-Q Summary - TradingView
Organogenesis (NASDAQ: ORGO) hit by 58% sales drop and $149M first-half loss - Stock Titan
Organogenesis Holdings Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 - marketscreener.com
Organogenesis Holdings Inc. Reports Second Quarter 2026 Financial Results - The Manila Times
Organogenesis Holdings reports Q2 2026 revenue $42.8M, net loss $96.3M - TradingView
Organogenesis Holdings Inc. Revises Revenue Guidance for the Second Half of the Year Ending December 31, 2026 - marketscreener.com
Organogenesis Holdings, Inc. Class A Revenue Breakdown – LS:A2PA31 - TradingView
Organogenesis Holdings Inc. expected to post a loss of 35 cents a shareEarnings Preview - TradingView
Organogenesis Holdings (ORGO) Shows Modest Gains, Trading Near Key Support ZoneETF AUM Growth - dars.gov.et
Organon: Q2 Earnings Snapshot - AOL.com
Organogenesis (ORGO) to Release Quarterly Earnings on Thursday - MarketBeat
Organogenesis Announces Publication of Peer-Reviewed Clinical Trial Results Demonstrating Clinical Benefit of Affinity™ in the Most Challenging and Complex Venous Leg Ulcers - The Manila Times
Organogenesis Holdings Inc (ORGO) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Organogenesis reports positive trial results for wound care product By Investing.com - Investing.com South Africa
Organogenesis reports positive trial results for wound care product - Investing.com
Organogenesis Announces Published RCT Results Showing Affinity Plus Standard of Care Improves Closure Rates in Complex Venous Leg Ulcers - Quiver Quantitative
Peer-reviewed Affinity trial finds higher closure in leg wounds over 24 months - Stock Titan
ORGO|Organogenesis Holdings Inc|Price:2.390|Chg%:-0.040 - TradingKey
Organogenesis Holdings Inc (ORGO) Cash Flow - TradingKey
ORGO|Organogenesis Holdings Inc|Price:2.550|Chg%:+0.160 - TradingKey
Organogenesis Holdings Inc (ORGO) Balance Sheet - TradingKey
Organogenesis Holdings Inc (ORGO) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Organogenesis Holdings Inc - TradingKey
Organogenesis Holdings Inc (ORGO) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Organogenesis Holdings Inc (ORGO) Institutional Confidence - TradingKey
TradingKey - TradingKey
Organogenesis Holdings, Inc. Class A Revenue Breakdown – DUS:2PQ - TradingView
Organogenesis Holdings Inc. (ORGO) stock price, news, quote and history - Yahoo Finance Singapore
ORGO INVESTOR ALERT: Hagens Berman, National Trial Attorneys, Encourages Organogenesis Holdings (ORGO) Investors with Substantial Losses to Contact Firm's Attorneys, Securities Fraud Class Action Filed - TMX Newsfile
Organogenesis Holdings Inc. (ORGO) Faces Downward Pressure as Shares Slip 3.5%Triple Bottom - dars.gov.et
ORGO|Organogenesis Holdings Inc|Price:2.335|Chg%:-0.095 - TradingKey
Organogenesis Holdings (ORGO) Slides 7.8% as Stock Tests Key Support ZoneIV Expansion Alert - dars.gov.et
3 Penny Stocks With Market Caps Over $100M To Consider - simplywall.st
Organogenesis Holdings (ORGO) Slips 1.87% as Resistance Holds; Key Levels in FocusSell Signal Alerts - dars.gov.et
1.61%
1.30%
자본화:
|
볼륨(24시간):